IMA vs MS
ImageneBio, Inc. (IMA) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
MS does not have a complete income-statement cache yet.
IMA currently screens at market cap $64.7M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the IMA and MS stock pages for the full models.
Not investment advice.